1-4 of 4
Vladimir Hanes
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Biosimilar Candidate ABP 959 As Compared with Eculizumab Reference Product in Paroxysmal Nocturnal Hemoglobinuria

Austin Kulasekararaj, Francesco Lanza, Alexandros Arvanitakis, Saskia M.C. Langemeijer, Satheesh Chonat, Vincent Chow, Jean Pan, Yaneth Saportas, Vladimir Hanes, Haby Henary
Journal: Blood
Blood (2022) 140 (Supplement 1): 8660–8662.
https://doi.org/10.1182/blood-2022-166722
Published: 2022
Journal Articles

Totality of Scientific Evidence in the Development of ABP 798, a Biosimilar to Rituximab

Dietger Niederwieser, MD PhD, Caroline Hamm, MD, Patrick Cobb, MD, Theingi Thway, PhD, Cecily Forsyth, FRACP, FRCPA, MBBS, Alessandra Tucci, MD, Vincent Delwail, Roman Hajek, MD PhD, Vladimir Hanes, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 35–36.
https://doi.org/10.1182/blood-2020-142723
Published: 2020
Journal Articles

Relationship between Pharmacokinetics and Antidrug Antibody Status of ABP 959, a Biosimilar Candidate to Eculizumab: Results from a Pharmacokinetic Similarity Study

Vladimir Hanes, MD, Jean Pan, Daniel T. Mytych, PhD, David Chien, MD, Vincent Chow
Journal: Blood
Blood (2019) 134 (Supplement_1): 3520.
https://doi.org/10.1182/blood-2019-128621
Published: 2019
Journal Articles

Clinical Characteristics of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): A Retrospective Chart Review Study

Vladimir Hanes, MD, Jean Pan, Vincent Chow
Journal: Blood
Blood (2019) 134 (Supplement_1): 4789.
https://doi.org/10.1182/blood-2019-130409
Published: 2019